- Conditions
- Hepatitis C Virus Infection
- Interventions
- SOF/VEL, Placebo
- Drug
- Lead sponsor
- Gilead Sciences
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 741 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 34
- States / cities
- Little Rock, Arkansas • Long Beach, California • Los Angeles, California + 27 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 73–96
of 12,508
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Parkinson's Disease, Idiopathic
- Interventions
- buntanetap/posiphen, Placebo
- Drug
- Lead sponsor
- Annovis Bio Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 523 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Sun City, Arizona • Fountain Valley, California + 35 more
- Conditions
- Parkinson Disease, Depression
- Interventions
- paroxetine, venlafaxine, placebo
- Drug · Other
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 115 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 15
- States / cities
- San Francisco, California • Gainesville, Florida • Miami, Florida + 11 more
- Conditions
- HIV Coinfection
- Interventions
- Maraviroc, Placebo
- Drug
- Lead sponsor
- ViiV Healthcare
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 138 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 24
- States / cities
- Bakersfield, California • Los Angeles, California • Oakland, California + 16 more
- Conditions
- Refractory Metastatic Colorectal Cancer
- Interventions
- Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil plus Bevacizumab Alone
- Drug
- Lead sponsor
- Delcath Systems Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 9
- States / cities
- Duarte, California • Santa Monica, California • Miami, Florida + 6 more
- Conditions
- Cervical Cancer, Cancer, Head and Neck Cancer
- Interventions
- ADXS11-001, MEDI4736
- Drug
- Lead sponsor
- Advaxis, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 17
- States / cities
- Los Angeles, California • New Haven, Connecticut • Jacksonville, Florida + 14 more
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®, Colecalciferol 2000 IU, Placebo
- Biological · Dietary Supplement
- Lead sponsor
- Diamyd Medical AB
- Industry
- Eligibility
- 12 Years to 28 Years
- Enrollment
- 321 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 13
- States / cities
- Newport Beach, California • Palo Alto, California • San Diego, California + 10 more
- Conditions
- CGA
- Interventions
- CGA, control
- Behavioral · Other
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Breast Neoplasms
- Interventions
- LY353381, tamoxifen
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 4
- States / cities
- Miami, Florida • Shreveport, Louisiana • Boston, Massachusetts + 1 more
- Conditions
- Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
- Interventions
- FOLFOX regimen, docetaxel, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin
- Drug
- Lead sponsor
- SWOG Cancer Research Network
- Network
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 508
- States / cities
- Mobile, Alabama • Little Rock, Arkansas • Auburn, California + 320 more
- Conditions
- Hot Flashes
- Interventions
- fezolinetant, placebo
- Drug
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 1,831 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 142
- States / cities
- Andalusia, Alabama • Birmingham, Alabama • Ensley, Alabama + 108 more
- Conditions
- Stress, Depression, Pregnancy, Blood Pressure
- Interventions
- Digital and Coordinated Maternial Care
- Behavioral
- Lead sponsor
- InovCares Connected Comprehensive Healthcare Corporation
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 384 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 2
- States / cities
- Miami, Florida • Tampa, Florida
- Conditions
- Relapsing Multiple Sclerosis (RMS)
- Interventions
- Ublituximab
- Biological
- Lead sponsor
- TG Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2032
- U.S. locations
- 19
- States / cities
- Pasadena, California • Denver, Colorado • Miami, Florida + 16 more
- Conditions
- Diabetic Foot Ulcers
- Interventions
- EpiCord, Standard of Care
- Biological · Other
- Lead sponsor
- MiMedx Group, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Carlsbad, California + 10 more
- Conditions
- Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
- Interventions
- MMRVNS, MMRV
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 15 Months to 6 Years
- Enrollment
- 1,209 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 17
- States / cities
- Birmingham, Alabama • Walnut Creek, California • Miami, Florida + 12 more
- Conditions
- Blood Clot, Trauma
- Interventions
- Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH)
- Drug
- Lead sponsor
- Major Extremity Trauma Research Consortium
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 12,424 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 19
- States / cities
- Tucson, Arizona • Miami, Florida • Indianapolis, Indiana + 16 more
- Conditions
- Migraine
- Interventions
- BHV-3500 (zavegepant), Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,753 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 116
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Canoga Park, California + 88 more
- Conditions
- Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma, Cholangiocarcinoma
- Interventions
- Niraparib
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 3
- States / cities
- Gainesville, Florida • Miami, Florida • Orlando, Florida
- Conditions
- HIV Prevention, Latino Men Who Have Sex With Men, Pharmacy
- Interventions
- PrEP & Soccer PrEP Navigation, CVS Health brochure
- Behavioral
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years to 54 Years · Male only
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Parkinson's Disease
- Interventions
- Lab Assay for seven genetic variants for Parkinson's Disease
- Device
- Lead sponsor
- Parkinson's Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 35,382 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 63
- States / cities
- Birmingham, Alabama • Chandler, Arizona • Phoenix, Arizona + 50 more
- Conditions
- Overweight and Obesity
- Interventions
- HIIT Exercise Training
- Other
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 18 Years to 44 Years · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Coral Gables, Florida
- Conditions
- Traditional Face to Face Training, Family Therapy Training and Implementation Platform (FTTIP)
- Interventions
- Training on CIFFTA competencies using Family Therapy Training and Implementation Platform (FTTIP), Training on CIFFTA competencies using Training and Coaching as Usual (TCAU)., Culturally Informed and Flexible Family-Based Treatment for Adolescents (CIFFTA)., Agency Readiness Consultation- Family Therapy Training and Implementation Platform (FTTIP), Agency Engagement and Orientation as Usual
- Other
- Lead sponsor
- Training and Implementation Associates
- Other
- Eligibility
- Not listed
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Miami, Florida
- Conditions
- SARS-CoV2, COVID-19
- Interventions
- VXA-CoV2-3.1, COMIRNATY®, VXA-CoV2-3.3
- Biological
- Lead sponsor
- Vaxart
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 5,485 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 145
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 126 more
- Conditions
- Renal Cell Carcinoma
- Interventions
- Nivolumab
- Drug
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 197 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 39
- States / cities
- Phoenix, Arizona • Bakersfield, California • Fullerton, California + 35 more